Short Interest Worth Watching: Is Buying TAKEDA PHARMACEUTICA (OTCMKTS:TKPHF), Having Higher Short Interest a Winning Strategy?

November 17, 2016 - By Peter Erickson   ·   0 Comments

Short Interest Worth Watching: Is Buying TAKEDA PHARMACEUTICA (OTCMKTS:TKPHF), Having Higher Short Interest a Winning Strategy?

The stock of TAKEDA PHARMACEUTICA (OTCMKTS:TKPHF) registered an increase of 3.89% in short interest. TKPHF’s total short interest was 2.01 million shares in November as published by FINRA. Its up 3.89% from 1.94M shares, reported previously. With 2,100 shares average volume, it will take short sellers 959 days to cover their TKPHF’s short positions. The stock last traded at $42.33 per share. It is up 13.20% since April 15, 2016 and is downtrending. It has underperformed by 17.83% the S&P500.

More important recent TAKEDA PHARMACEUTI NPV (OTCMKTS:TKPHF) news were published by: Seekingalpha.com which released: “ASH – Ninlaro Throws Down The All-Oral Gauntlet To Kyprolis” on December 07, 2015, also Seekingalpha.com published article titled: “Synergy Pharmaceuticals: Attractive Acquisition Target”, Seekingalpha.com published: “NPS Pharmaceuticals: Misunderstood Assets And Compelling Value Play” on June 27, 2012. More interesting news about TAKEDA PHARMACEUTI NPV (OTCMKTS:TKPHF) was released by: Seekingalpha.com and their article: “Onyx – A ‘Must Own’ Biotech For 2013” with publication date: January 28, 2013.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Peter Erickson


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>